A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (CADENCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04945460

Recruitment Status : Recruiting

First Posted : June 30, 2021

Last Update Posted : March 29, 2022

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Acceleron Pharma Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	August 2023
Estimated Study Completion Date :	June 2025

To Top